Treatment Withdrawal Following Remission in Juvenile Idiopathic Arthritis: A Systematic Review of the Literature
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment Withdrawal Following Remission in Juvenile Idiopathic Arthritis: A Systematic Review of the Literature
Authors
Keywords
-
Journal
PEDIATRIC DRUGS
Volume 21, Issue 6, Pages 469-492
Publisher
Springer Science and Business Media LLC
Online
2019-11-01
DOI
10.1007/s40272-019-00362-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treat-to-target using first-line recombinant interleukin-1 receptor antagonist monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five year follow-up study
- (2019) Nienke M. ter Haar et al. Arthritis & Rheumatology
- 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis
- (2019) Sheila T. Angeles‐Han et al. ARTHRITIS CARE & RESEARCH
- 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
- (2019) Michael M. Ward et al. ARTHRITIS CARE & RESEARCH
- Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA
- (2018) Jens Klotsche et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitors
- (2018) Timothy Beukelman et al. ANNALS OF THE RHEUMATIC DISEASES
- Normal MRI findings of the knee in patients with clinically active juvenile idiopathic arthritis
- (2018) E. Charlotte van Gulik et al. EUROPEAN JOURNAL OF RADIOLOGY
- Flares of Disease in Children with Clinically Inactive Juvenile Idiopathic Arthritis Were Not Correlated with Ultrasound Findings
- (2018) Yongdong Zhao et al. JOURNAL OF RHEUMATOLOGY
- Predictors of Flare Following Etanercept Withdrawal in Patients with Rheumatoid Factor–negative Juvenile Idiopathic Arthritis Who Reached Remission while Taking Medication
- (2018) Angela Aquilani et al. JOURNAL OF RHEUMATOLOGY
- Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis: Clinical and Laboratory Correlates of Remission Duration
- (2018) Gabriele Simonini et al. ARTHRITIS CARE & RESEARCH
- Risk, Timing and Predictors of Disease Flare after Discontinuation of Anti-Tumor Necrosis Factor (TNF) Therapy in Children with Polyarticular Forms of Juvenile Idiopathic Arthritis (JIA) in Clinical Inactive Disease
- (2018) Daniel J. Lovell et al. Arthritis & Rheumatology
- Long term outcomes following achievement of clinically inactive disease in juvenile idiopathic arthritis: the importance of definition
- (2018) Stephanie JW Shoop-Worrall et al. Arthritis & Rheumatology
- High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy
- (2018) Nirit Mor-Vaknin et al. Arthritis & Rheumatology
- The time of DMARD start in Juvenile Idiopathic Arthritis determines the likelihood of a drug-free remission in young adulthood
- (2018) Kirsten Minden et al. ARTHRITIS CARE & RESEARCH
- Serum S100A8/A9 and S100A12 Levels in Children with Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinical Inactive Disease During and Flare after Discontinuation of Anti-TNF Therapy
- (2018) Claas H. Hinze et al. Arthritis & Rheumatology
- Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial
- (2018) Petra Hissink Muller et al. ANNALS OF THE RHEUMATIC DISEASES
- Tapering and Discontinuation of Biologics in Patients with Psoriatic Arthritis with Low Disease Activity
- (2018) Weiyu Ye et al. DRUGS
- Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus
- (2018) Alberto Martini et al. JOURNAL OF RHEUMATOLOGY
- Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance
- (2017) Daniel B. Horton et al. JOURNAL OF RHEUMATOLOGY
- Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis
- (2017) Gabriele Simonini et al. JOURNAL OF RHEUMATOLOGY
- Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
- (2017) Sonja Falvey et al. Pediatric Rheumatology
- Patients with juvenile idiopathic arthritis in clinical remission with positive power Doppler signal in joint ultrasonography have an increased rate of clinical flare: a prospective study
- (2017) Vanessa Bugni Miotto e Silva et al. Pediatric Rheumatology
- Dosing down with biologic therapies: a systematic review and clinicians’ perspective
- (2017) Christopher J Edwards et al. RHEUMATOLOGY
- A multi-biomarker score measuring disease activity in rheumatoid arthritis patients tapering adalimumab or etanercept: predictive value for clinical and radiographic outcomes
- (2017) Chantal A. M. Bouman et al. RHEUMATOLOGY
- Lack of Concordance in Interrater Scoring of the Provider's Global Assessment of Children With Juvenile Idiopathic Arthritis With Low Disease Activity
- (2017) Janalee Taylor et al. ARTHRITIS CARE & RESEARCH
- Comparative Assessment of the Different American College of Rheumatology/European League Against Rheumatism Remission Definitions for Rheumatoid Arthritis for Their Use as Clinical Trial End Points
- (2017) Michael E. Mack et al. Arthritis & Rheumatology
- Review: Genetics and the Classification of Arthritis in Adults and Children
- (2017) Peter A. Nigrovic et al. Arthritis & Rheumatology
- Little Evidence for Usefulness of Biomarkers for Predicting Successful Dose Reduction or Discontinuation of a Biologic Agent in Rheumatoid Arthritis: A Systematic Review
- (2017) Lieke Tweehuysen et al. Arthritis & Rheumatology
- Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions
- (2016) Georg Schett et al. ANNALS OF THE RHEUMATIC DISEASES
- Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis
- (2016) Marc Breitbach et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers
- (2016) Lianne Kearsley-Fleet et al. RHEUMATOLOGY
- Uveitis Reactivation in Children Treated With Tumor Necrosis Factor Alpha Inhibitors
- (2015) Melissa A. Lerman et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort
- (2015) Jaime Guzman et al. ANNALS OF THE RHEUMATIC DISEASES
- Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment
- (2015) Juergen Rech et al. ANNALS OF THE RHEUMATIC DISEASES
- Prediction of long-term remission of oligo/polyarticular juvenile idiopathic arthritis with S100A12 and vascular endothelial growth factor
- (2015) Yuichi Yamasaki et al. Modern Rheumatology
- Impact of Medication Withdrawal Method on Flare-Free Survival in Patients with Juvenile Idiopathic Arthritis on Combination Therapy
- (2015) Caroline Y. Chang et al. ARTHRITIS CARE & RESEARCH
- MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis
- (2015) Janneke Anink et al. ARTHRITIS RESEARCH & THERAPY
- The Humanistic and Economic Burden of Juvenile Idiopathic Arthritis in the era of Biologic Medication
- (2015) Wendy Gidman et al. Current Rheumatology Reports
- The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
- (2014) Jaime Guzman et al. ANNALS OF THE RHEUMATIC DISEASES
- Extension Study of Participants from the Trial of Early Aggressive Therapy in Juvenile Idiopathic Arthritis
- (2014) C. A. Wallace et al. JOURNAL OF RHEUMATOLOGY
- The Biologic Basis of Clinical Heterogeneity in Juvenile Idiopathic Arthritis
- (2014) Simon W. M. Eng et al. Arthritis & Rheumatology
- Defining criteria for high disease activity in juvenile idiopathic arthritis based on the Juvenile Arthritis Disease Activity Score
- (2013) Alessandro Consolaro et al. ANNALS OF THE RHEUMATIC DISEASES
- Prevalence and incidence of juvenile idiopathic arthritis: A systematic review
- (2013) Sigrid Thierry et al. JOINT BONE SPINE
- Risk factors associated with the relapse of uveitis in patients with juvenile idiopathic arthritis: a preliminary report
- (2013) Ujwala S. Saboo et al. JOURNAL OF AAPOS
- Recurrence of Uveitis after Discontinuation of Infliximab
- (2013) Akbar Shakoor et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?
- (2013) J. Anink et al. RHEUMATOLOGY
- Clinical trial of etanercept tapering in juvenile idiopathic arthritis during remission
- (2013) Yubo Cai et al. RHEUMATOLOGY INTERNATIONAL
- Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-α therapy: a clinical practice observational study of patients who discontinued treatment
- (2013) Estíbaliz Iglesias et al. RHEUMATOLOGY INTERNATIONAL
- Validation of Relapse Risk Biomarkers for Routine Use in Patients With Juvenile Idiopathic Arthritis
- (2013) Friederike Rothmund et al. ARTHRITIS CARE & RESEARCH
- Ultrasound-detected synovial abnormalities are frequent in clinically inactive juvenile idiopathic arthritis, but do not predict a flare of synovitis
- (2012) Silvia Magni-Manzoni et al. ANNALS OF THE RHEUMATIC DISEASES
- Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study
- (2012) Joachim Gerss et al. ANNALS OF THE RHEUMATIC DISEASES
- Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score
- (2012) Alessandro Consolaro et al. ARTHRITIS AND RHEUMATISM
- Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis
- (2012) Mary Chester M. Wasko et al. ARTHRITIS AND RHEUMATISM
- Clinical remission in juvenile idiopathic arthritis after termination of etanercept
- (2012) Jacek Postępski et al. RHEUMATOLOGY INTERNATIONAL
- Clinical outcomes after withdrawal of anti-tumor necrosis factor α therapy in patients with juvenile idiopathic arthritis: A twelve-year experience
- (2011) Kevin Baszis et al. ARTHRITIS AND RHEUMATISM
- Psoriatic juvenile idiopathic arthritis
- (2011) Matthew L. Stoll et al. CURRENT OPINION IN RHEUMATOLOGY
- Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis
- (2011) Marieke H. Otten et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus
- (2011) L-W Kwok et al. LUPUS
- American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis
- (2011) Carol A. Wallace et al. ARTHRITIS CARE & RESEARCH
- Defining Juvenile Idiopathic Arthritis Remission and Optimum Time for Disease-Modifying Anti-Rheumatic Drug Withdrawal
- (2011) Thomas Broughton et al. PEDIATRIC DRUGS
- Relapse Rate of Uveitis Post-Methotrexate Treatment in Juvenile Idiopathic Arthritis
- (2010) Viera Kalinina Ayuso et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis
- (2010) Angelo Ravelli et al. ARTHRITIS AND RHEUMATISM
- Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in RemissionA Randomized Clinical Trial
- (2010) Dirk Foell JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Discontinuation of Etanercept After Successful Treatment in Patients with Juvenile Idiopathic Arthritis
- (2010) A. REMESAL et al. JOURNAL OF RHEUMATOLOGY
- When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis
- (2009) F H M Prince et al. ANNALS OF THE RHEUMATIC DISEASES
- The meaning of clinical remission in polyarticular juvenile idiopathic arthritis: Gene expression profiling in peripheral blood mononuclear cells identifies distinct disease states
- (2009) Nicholas Knowlton et al. ARTHRITIS AND RHEUMATISM
- Multidisciplinary approach of organic catatonia in children and adolescents may improve treatment decision making
- (2008) Bertrand Lahutte et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started